Bookmark and Share
Glucose (CID 5793) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(1)
 
 
Inactive(181)
 
 
Inconclusive(5)
 
 
Unspecified(47)
 
 
Top Targets:
NR LBD ER(14)
 
 
NR LBD AR(14)
 
 
NR LBD PPAR(10)
 
 
NR LBD GR(8)
 
 
NR LBD TR(8)
 
 
BioAssay Types:
Confirmatory(137)
 
 
 
Literature(47)
 
 
 
Summary(39)
 
 
Screening(7)
 
 
BioActivity Types:
Potency(168)
 
 
 
Ki(6)
 
 
IC50(4)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 168    Data Row: 234   Total Pages: 12   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID48415870]
DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other]
View
2
[SID104243011]
IC50 30Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins [AID377830, Type: Literature]
View
3
[SID104243011]
IC50 30Antioxidant activity assessed as authentic peroxynitrite free radical scavenging activity after 30 mins [AID377831, Type: Literature]
View
4
[SID104243011]
IC50 30Antioxidant activity assessed as 3-morpholinosydnonimine-derived peroxynitrite free radical scavenging activity after 30 mins [AID377832, Type: Literature]
View
5
[SID104243011]
Ki 1698.24Inhibitory activity against glycogen phosphorylase, activity expressed as -logKi [AID73810, Type: Literature]
View
6
[SID104243011]
Ki 1698.24Affinity on glycogen phosphorylase (GP) enzyme. [AID73821, Type: Literature]
View
7
[SID104243011]
Ki 1700Inhibition of rabbit glycogen phosphorylase B enzyme [AID73815, Type: Literature]
View
8
[SID104243011]
Ki 1700The compound was evaluated for the inhibition of glycogen phosphorylase [AID73819, Type: Literature]
View
9
[SID104243011]
Ki 7400Inhibitory binding constant against glycogen phosphorylase B [AID73826, Type: Literature]
View
10
[SID104243011]
Ki 7400Inhibitory activity against muscle Glycogen Phosphorylase b [AID141119, Type: Literature]
View
11
[SID104243011]
IC50 500000Inhibition of Cryptosporidium parvum recombinant Galactose/N-acetylgalactosamine-specific lectin binding to Caco2A cells [AID381596, Type: Literature]
View
12
[SID104243011]
Inhibition of Cryptosporidium parvum recombinant Galactose/N-acetylgalactosamine-specific lectin binding to Caco2A cells relative to galactose [AID381597, Type: Literature]
View
13
[SID104243011]
Activation of AMPKalpha in rat L6 cells assessed as ATP concentration per mg of protein at 5 mM [AID389773, Type: Literature]
View
14
[SID104243011]
Activation of AMPKalpha in rat L6 cells assessed as ATP concentration per mg of protein at 23 mM [AID389774, Type: Literature]
View
15
[SID104243011]
Absolute bioavailability in human [AID481439, Type: Literature]
View
16
[SID104243011]
Aqueous diffusivity at 37C [AID481441, Type: Literature]
View
17
[SID104243011]
Transcellular permeability at pH 6.5 calculated from in vitro P app values in Caco-2 and/or MDCK cells [AID481442, Type: Literature]
View
18
[SID104243011]
Octanol-water partition coefficient, log P of the compound [AID481444, Type: Literature]
View
19
[SID104243011]
Effective permeability across human jejunum [AID481446, Type: Literature]
View
20
[SID104243011]
Ratio of Kcat to Km for Neisseria meningitidis lgtC [AID500279, Type: Literature]
View